{"name":"Ross D. Zafonte, MD","slug":"ross-d-zafonte-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Levodopa / Carbidopa","genericName":"Levodopa / Carbidopa","slug":"levodopa-carbidopa","indication":"Parkinson's disease","status":"marketed"}]}],"pipeline":[{"name":"Levodopa / Carbidopa","genericName":"Levodopa / Carbidopa","slug":"levodopa-carbidopa","phase":"marketed","mechanism":"Levodopa is converted to dopamine in the brain to replace deficient neurotransmitter levels, while carbidopa inhibits premature conversion of levodopa in the periphery, allowing more to reach the brain.","indications":["Parkinson's disease","Parkinsonism secondary to carbon monoxide poisoning or manganese intoxication"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTE1WcXh5RDJGOG5HaVBNYWk4OWVnM045d1pMb0VYdExabmpCeFNGM0U2X3JNeWsxeUE5a09RTVRwczIwRnpLeDRxdmcyaGtjOHY2SkNXdG9ITmhIa2l1RzVOOXRNMEZ3Sm9vT3VnSkNGdkwyS2M?oc=5","date":"2024-12-04","type":"trial","source":"Psychiatry Online","summary":"Multicenter Evaluation of Memory Remediation in Traumatic Brain Injury With Donepezil: A Randomized Controlled Trial - Psychiatry Online","headline":"Multicenter Evaluation of Memory Remediation in Traumatic Brain Injury With Donepezil: A Randomized Controlled Trial","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}